1.The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma.
Shuang Huan LIU ; Yi Ming MA ; Ya Nan ZHANG ; Xin Hua ZHAO ; Hong Ying WANG ; Bin LI
Chinese Journal of Oncology 2023;45(1):64-73
Objective: To investigate the expression and significance of protease activated receptor 2 (PAR2) in ovarian epithelial carcinoma. Methods: PAR2 mRNA expression levels in 410 cases of epithelial ovarian carcinoma and 88 cases of human normal ovary were analyzed from cancer Genome Atlas (TCGA) database and tissue genotypic expression database (GTEx). Immunohistochemical (IHC) staining of PAR2 protein was performed in 149 patients with ovarian cancer who underwent primary surgical treatment at Cancer Hospital of Chinese Academy of Medical Sciences. Then the relationship between mRNA/protein expression of PAR2 and clinicopathological features and prognosis was analyzed. Gene functions and related signaling pathways involved in PAR2 were studied by enrichment analysis. Results: The mRNA expression of PAR2 in epithelial ovarian carcinoma was significantly higher than that in normal ovarian tissue (3.05±0.72 vs. 0.33±0.16, P=0.004). There were 77 cases showing positive and 19 showing strong positive of PAR2 IHC staining among the 149 patients, accounting for 64.4% in total. PAR2 mRNA/protein expression was closely correlated with tumor reduction effect and initial therapeutic effect (P<0.05). Survival analysis showed that the progression free survival time (P=0.033) and overall survival time (P=0.011) in the group with high PAR2 mRNA expression was significantly lower than that in the low PAR2 mRNA group. Multivariate analysis showed tumor reduction effect, initial therapeutic effect were independent prognostic factors on both progression-free survival and overall survival (P<0.05). The progression-free survival (P=0.016) and overall survival (P=0.038) of the PAR2 protein high expression group was significantly lower than that of the low group. Multivariate analysis showed PAR2 expression, initial treatment effect and chemotherapy resistance were independent prognostic factors on both progression-free survival and overall survival (P<0.05). Based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), PAR2 target genes were mainly enriched in function related to intercellular connection, accounting for 40%. Gene enrichment analysis (GSEA) showed that the Wnt/β-catenin signaling pathway (P=0.023), the MAPK signaling pathway (P=0.029) and glycolysis related pathway (P=0.018) were enriched in ovarian cancer patients with high PAR2 mRNA expression. Conclusions: PAR2 expression is closely related to tumor reduction effect, initial treatment effect and survival of ovarian cancer patients. PAR2 may be involved in Wnt/β-catenin signaling pathway and intercellular connection promoting ovarian cancer invasion and metastasis.
Female
;
Humans
;
Carcinoma, Ovarian Epithelial
;
Receptor, PAR-2
;
Ovarian Neoplasms/pathology*
;
Prognosis
;
RNA, Messenger/metabolism*
2.MUC16: The Novel Target for Tumor Therapy.
Ruyun GAO ; Ning LOU ; Xiaohong HAN ; Yuankai SHI
Chinese Journal of Lung Cancer 2022;25(7):452-459
Mucin16 (MUC16), also known as carbohydrate antigen 125 (CA125), is a glycoprotein antigen that can be recognized by the monoclonal antibody OC125 detected from epithelial ovarian carcinoma antigen by Bast et al in 1981. CA125 is not present in normal ovarian tissue but is usually elevated in the serum of epithelial ovarian carcinoma patients. CA125 is the most commonly used serologic biomarker for the diagnosis and recurrence monitoring of epithelial ovarian carcinoma. MUC16 is highly expressed in varieties of tumors. MUC16 can interact with galectin-1/3, mesothelin, sialic acid-binding immunoglobulin-type lectins-9 (Siglec-9), and other ligands. MUC16 plays an important role in tumor genesis, proliferation, migration, invasion, and tumor immunity through various signaling pathways. Besides, therapies targeting MUC16 have some significant achievements. Related preclinical studies and clinical trials are in progress. MUC16 may be a potential novel target for tumor therapy. This article will review the mechanism of MUC16 in tumor genesis and progression, and focus on the research actuality of MUC16 in tumor therapy. This article also provides references for subsequent tumor therapy studies targeting MUC16.
.
CA-125 Antigen/metabolism*
;
Carcinoma, Ovarian Epithelial
;
Female
;
Humans
;
Lung Neoplasms
;
Membrane Proteins/metabolism*
;
Ovarian Neoplasms/pathology*
3.Phosphatase of regenerating liver-3 (PRL-3) and tumor metastasis.
Li-rong PENG ; Cheng-chao SHOU
Chinese Journal of Oncology 2007;29(1):1-3
Animals
;
Colonic Neoplasms
;
metabolism
;
pathology
;
Female
;
Humans
;
Liver Neoplasms
;
metabolism
;
secondary
;
Lymphatic Metastasis
;
Neoplasm Proteins
;
metabolism
;
Ovarian Neoplasms
;
metabolism
;
pathology
;
Protein Tyrosine Phosphatases
;
metabolism
;
Stomach Neoplasms
;
metabolism
;
pathology
4.Expression of the HIF-2α in epithelial ovarian cancer and clinical significance.
Qin WANG ; Kuan PENG ; Ling HE
Journal of Central South University(Medical Sciences) 2014;39(9):889-893
OBJECTIVE:
To investigate the expression of hypoxia inducible factor 2α (HIF-2α) in every clinical stage and the pathological grade of epithelial ovarian cancer, and to discuss the role of HIF-2α in carcinogenesis, progression and outcomes of epithelial ovarian tumors.
METHODS:
Protein expression of HIF-2α in epithelial ovarian tissue from 77 randomly selected specimens was detected by SP immunohistochemistry staining. The relation between the expression of HIF-2α and prognosis of 40 patients with epithelial ovarian cancer was analyzed by Cox regression model.
RESULTS:
There was positive relation between the positivity rates of HIF-2α and malignant grade, FIGO stage, histological grade and invasive metastasis. The live time of the patients with HIF-2α positive expression was shorter than those with negative expression.
CONCLUSION
HIF-2α may play an important role in the genesis, development, invasion and metastasis of ovarian cancer and it may possess the vital clinical significance for prognosis evaluation.
Basic Helix-Loop-Helix Transcription Factors
;
metabolism
;
Carcinoma, Ovarian Epithelial
;
Disease Progression
;
Female
;
Humans
;
Immunohistochemistry
;
Neoplasms, Glandular and Epithelial
;
diagnosis
;
metabolism
;
Ovarian Neoplasms
;
diagnosis
;
metabolism
;
Prognosis
5.Detection of laminin in serum and ascites from patients with epithelial ovarian tumor.
Yongli CHU ; Yuanxian YANG ; Meihua LIN ; Zehua WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2002;22(1):58-68
The change in serum laminin (LN) level and its clinical significance in epithelial ovarian tumor were investigated. The LN levels in serum and ascites samples from 69 patients with epithelial ovarian tumor and 42 cases as control group before and after operation were analyzed by radioimmunoassay. The results showed that the serum LN levels in the patients with malignant tumors (157.85 +/- 14.37 ng/ml) were significantly higher than that in the control group (125.14 +/- 7.03 ng/ml) and in the patients with benign tumors (128.36 +/- 8.75 ng/ml) (both P < 0.01) before operation. The serum LN levels in the malignant group were decreased significantly after operation as compared with those before operation (P < 0.05). The serum LN levels in low-differentiated tumors was higher than those in moderate-differentiated tumors and high-differentiated tumors (P < 0.05). The LN levels in ascites (172.94 +/- 15.26 ng/ml) was significantly higher than in serum (161.34 +/- 6.59 ng/ml) (P < 0.05) in malignant tumors. The serum LN levels in the patients with lymph node metastasis (165.41 +/- 19.91 ng/ml) was obviously higher than those without lymph node metastasis (152.35 +/- 10.34 ng/ml) (P < 0.05). It was concluded that LN levels in serum and acistis were remarkably increased in malignant epithelial ovarian tumors, suggesting that LN might be one of important diameters reflecting tumor biological characteristics.
Ascitic Fluid
;
metabolism
;
Biomarkers, Tumor
;
blood
;
metabolism
;
Carcinoma
;
blood
;
metabolism
;
Female
;
Humans
;
Laminin
;
blood
;
metabolism
;
Male
;
Ovarian Neoplasms
;
metabolism
7.Effect of exosome derived from ovarian cancer cell on the differentiation of fibroblast.
Dan ZHANG ; Ke Juan SONG ; Yuan Zhong REN ; Lei SUI ; Qin YAO
Chinese Journal of Oncology 2022;44(7):737-742
Objective: To study the effects of exosome secreted by ovarian cancer (OC) cell on the differentiation and metastasis of normal fibroblasts (NFs). Methods: NFs were collected from patients who underwent hysteromyoma resection in the Affiliated Hospital of Qingdao University from May to December 2019. Exosome was extracted from the culture supernatant of SKOV3 cells by using ultra-high-speed centrifugation. The NFs were co-cultured with condition medium (CM), exosome of SKOV3 (SKOV3-exo) and control medium. The expression levels of fibroblast activation protein (FAP) and α-smooth muscle actin (α-SMA) were detected by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot. The metastatic ability of NFs was detected by Transwell array. Results: Under the transmission electron microscope, the extracellular vesicles extracted from the culture supernatant of SKOV3 were 30-100 nm in diameter with cup holder-like bilayer membrane structure, and the protein expression levels of TSG101 and HSP27 in exosomes (1.00±0.05 and 1.12±0.13) were higher than those of ovarian cancer SKOV3 cells (0.22±0.21 and 0.36±0.14, respectively, P<0.05). PKH67 fluorescently labeled exosomes could be taken up by NFs. The expression levels of α-SMA and FAP mRNA in CM group(2.91±0.15 and 3.21±0.33)and SKOV3-exo group (3.50±0.21 and 4.63±0.24, respectively) were higher than that in blank group (1.00±0.06 and 1.00±0.13, P<0.05). The protein expression levels of α-SMA and FAP in CM group and SKOV3-exo group (0.89±0.11 and 1.25±0.09, 0.81±0.09 and 1.20±0.12) were higher than those in the blank group (0.12±0.31 and 0.11±0.19, respectively, P<0.05). The migrated numbers of cells in the CM group and SKOV3-exo group [(215.01±14.80) and (389.72±19.43), respectively] were higher than that in the blank group [(113.73±4.70), P<0.05]. Conclusion: The exosome secreted by SKOV3 cells can be taken up by NFs, which makes it to differentiate into cancer associated fibroblasts (CAFs) and significantly enhances its metastatic ability, indicating that OC cells may promote the transformation of normal ovarian mesenchymal fibroblasts to CAFs through exosome pathways, and then promote the development of ovarian cancer.
Carcinoma, Ovarian Epithelial
;
Cell Differentiation
;
Cell Line, Tumor
;
Cell Proliferation
;
Coculture Techniques
;
Exosomes
;
Female
;
Fibroblasts
;
Humans
;
Ovarian Neoplasms/metabolism*
8.Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer.
Ya Nan ZHANG ; Bin LI ; Yu Qing LI ; Shuang Huan LIU ; Hong Yi HOU ; Kun Yu WANG ; Miao AO ; Yan SONG
Chinese Journal of Obstetrics and Gynecology 2023;58(5):368-377
Objective: To investigate the mechanism of signal transducer and activator of transcription 3 (STAT3) and cancer associated fibroblasts (CAF) jointly generate chemo-resistance in epithelial-ovarian cancer and their effect on prognosis. Methods: A total of 119 patients with high-grade ovarian serous cancer who received surgery in Cancer Hospital of Chinese Academy of Medical Sciences from September 2009 to October 2017 were collected. The clinico-pathological data and follow-up data were complete. Multivariate Cox regression model was used to analyze the prognostic factors. Ovarian cancer tissue chips of patients in our hospital were prepared. EnVision two-step method immunohistochemistry was used to detect the protein expression levels of STAT3, the specific markers of CAF activation, fibroblast activating protein (FAP), and type Ⅰ collagen (COL1A1) secreted by CAF. The relationship between the expression of STAT3, FAP, COL1A1 protein and drug resistance and prognosis of ovarian cancer patients was analyzed, and the correlation between the expression of three proteins was analyzed. These results were verified through the gene expression and prognostic information of human ovarian cancer tissues collected in the GSE26712 dataset of gene expression omnibus (GEO) database. Results: (1) Multivariate Cox regression model analysis showed that chemotherapy resistance was an independent risk factor for overall survival (OS) of ovarian cancer (P<0.001). (2) The expression levels of STAT3, FAP, and COL1A1 proteins in chemotherapy resistant patients were significantly higher than those in chemotherapy sensitive patients (all P<0.05). Patients with high expression of STAT3, FAP, and COL1A1 had significantly shorter OS than those with low expression (all P<0.05). According to the human ovarian cancer GSE26712 dataset of GEO database, patients with high expression of STAT3, FAP, and COL1A1 also showed shorter OS than patients with low expression (all P<0.05), the verification results were consistent with the detection results of ovarian cancer patients in our hospital. (3) Correlation analysis showed that the protein level of STAT3 was positively correlated with FAP and COL1A1 in our hospital's ovarian cancer tissue chips (r=0.47, P<0.001; r=0.30, P=0.006), the analysis of GEO database GSE26712 dataset showed that the expression of STAT3 gene and FAP, COL1A1 gene were also significantly positively correlated (r=0.31, P<0.001; r=0.52, P<0.001). Conclusion: STAT3 and CAF could promote chemotherapy resistance of ovarian cancer and lead to poor prognosis.
Female
;
Humans
;
Cancer-Associated Fibroblasts/pathology*
;
Carcinoma, Ovarian Epithelial
;
Ovarian Neoplasms/pathology*
;
Prognosis
;
STAT3 Transcription Factor/metabolism*
;
Drug Resistance, Neoplasm
9.A Clinicopathological Study on Stage I Ovarian Adult Granulosa Cell Tumors with Recurrence within 5 Years.
Zhen HUO ; Li-Na GUO ; Xiao-Hua SHI ; Zhi-Yong LIANG ; Jin-Hui WANG ; Xu-Guang LIU ; Tao LU ; Jun-Yi PANG
Chinese Medical Journal 2018;131(23):2877-2879
Adult
;
Female
;
Granulosa Cell Tumor
;
metabolism
;
pathology
;
Humans
;
Male
;
Middle Aged
;
Ovarian Neoplasms
;
metabolism
;
pathology
10.Differentially expressed proteins between normal ovaries and ovarian cancer tissues screened by the protein chips.
Fei CHEN ; Jia-Xin YANG ; Ming WU ; Keng SHEN
Acta Academiae Medicinae Sinicae 2009;31(3):378-380
OBJECTIVETo explore the differentially expressed proteins between normal ovaries and ovarian cancer tissues using the protein chips.
METHODSTissues of 11 epithelial ovarian cancer (EOC) and 11 matched normal ovaries were labeled with cy3 and cy5 fluorescent dyes and then were hybridized with 512 monoclonal protein antibody chips. The internally normalized ratio (INR) was calculated according to the intensity of fluorescence of each protein spots. The value of INR > 2.0 or < 0.7 was considered as the cut-value to filtrate the differentially expressed proteins between tissues of EOC and normal ovaries.
RESULTSThirty one differentially expressed proteins were found between tissues of EOC and normal ovaries, in which 17 up-regulated and 14 down-regulated proteins involved in the transcription, proliferation, signal conduction, and apoptosis of cells.
CONCLUSIONAntibody chips can effectively screen the differentially expressed proteins between normal ovaries and ovarian cancer tissues.
Adult ; Aged ; Female ; Humans ; Middle Aged ; Neoplasms, Glandular and Epithelial ; metabolism ; Ovarian Neoplasms ; metabolism ; Ovary ; metabolism ; Protein Array Analysis ; Proteomics